Regenerative corneal trial underway
I have ChatGPT giving me an update on this trial every few months. Thought it might be useful to flag to others. Extremely early days but something to perhaps keep an eye on (pun intended!):
TN‑001 (TheiaNova)
The first-in-human TN‑001 trial is now actively underway in Australia, with first patient dosing confirmed earlier this year. The study remains a small Phase 1/2 safety and proof‑of‑concept trial. No human efficacy data have been published yet.
ClinicalTrials.gov +2
Key points:
TN‑001 combines TGF‑β3 with dexamethasone as a topical regenerative therapy.
The goal is biological collagen regeneration rather than conventional mechanical stiffening.
The trial is still focused primarily on safety/tolerability and dose selection.
No peer‑reviewed outcomes on visual improvement, corneal flattening, or long‑term stabilisation have been released.
At this stage, the signal is still: “interesting science, but unproven clinically”.
https://clinicaltrials.gov/study/NCT07388069?utm\_source=chatgpt.com